Heterozygous deletions in the 15q13.3 region are associated with several neuropsychiatric disorders including autism, schizophrenia, and attention deficit hyperactivity disorder. Several genes within the 15q13.3 deletion region may play a role in neuronal dysfunction, based on association studies in humans and functional studies in mice, but the intermediate molecular mechanisms remain unknown.
to determine the effects of the heterozygous 15q13.3 microdeletion on expression both within the deletion and genome-wide. We first looked for evidence of haploinsuffiency or dosage compensation within the 15q13.3 microdeletion, which contains seven protein-coding genes. In iPSCs, five genes, KLF13, MTMR10, OTUD7A, FAN1, and ARHGAP11B, showed significantly decreased gene expression in 15q13.3 deletion cases (padj <= 0.05). Additionally, CHRNA7 was expressed at very low levels and was non-significantly decreased in deletion cases ( Fig. 2a ). In iNs, six genes, KLF13, MTMR10, OTUD7A, FAN1, ARHGAP11B, and CHRNA7, were significantly decreased in 15q13.3 deletion cases (padj <= 0.05). The gene TRPM1 was not detected above threshold levels in iPSCs or iNs ( Figs. 2a, b ). We also analyzed the gene expression data set for a position effect, in which genes located near but outside the 15q13.3 microdeletion are affected. In both iPSCs and iNs, no significant enrichment was observed for genes within 5 Mb from the 15q13.3 deletion. Using Webgestalt, we carried out an analysis to determine if any cytogenetic bands were enriched in differentially expressed genes. As expected, the 15q13.3 locus was enriched in both iPSCs and iNs (padj <= 0.05). In addition, the locus 10q11.2 was significantly enriched in iPSCs. One of the differentially expressed genes within this region is GPRIN2, which regulates neurite outgrowth and has been identified as being affected by copy number variation in several patients with autism [31] .
We observed genome-wide changes in the expression of genes as a result of the 15q13. Tables S1, S2). The much larger number of DE genes at the iN level compared with the iPSC level suggests the 15q13.3 microdeletion may have stronger downstream effects in a more relevant cell type with regard to the associated neuropsychiatric phenotypes. Out of 41 genes overlapping between the iPSC and iN DE gene lists, all showed the same direction of fold change in gene expression except for S100A10, which shifted from decreased expression in deletion cases for iPSCs to increased expression in deletion cases for iNs. S100A100, a member of the S-100 family of calcium binding proteins, is involved in depression-like behaviors through regulation of serotonin receptor activity [32] . At the iN stage, a number of genes were identified as differentially expressed that have been previously implicated in neuropsychiatric disorders associated with the 15q13.3 microdeletion. These genes include VIPR2, PRODH, and DGCR6 for schizophrenia [33] [34] [35] ; CACNG3, SCN8A, SPATA5, and KCNA2 for epilepsy [36] [37] [38] [39] ; and LINS1 and DCPS for intellectual disability [40] [41] [42] .
Using the lists of differentially expressed genes (padj <= 0.05), we performed gene set enrichment analysis using Webgestalt. In iPSCs, no gene ontology molecular function terms were significantly enriched. In iNs, we identified several significant gene ontology molecular function terms, with the top terms grouping into the categories of ribosome function, nucleic acid binding, Wnt binding, and sulfur compound binding ( Fig. 2e ). In addition, we performed over-representation analysis using Ingenuity Pathway Analysis (IPA) to identify enriched canonical pathways. Within iNs, there was an enrichment of the EIF2 signaling pathway, which is involved in translational control (padj <= 0.05).
The genes driving this enrichment, which were all significantly up-regulated in 15q13.3 deletion samples, included AGO2, which plays a key role in RNA interference; EIF2AK2, a kinase that phosphorylates translation initiation factor EIF2S1; and 12 ribosomal protein genes ( Fig. 2f ). 
DNA methylation analysis
We performed genome-wide targeted-capture bisulfite sequencing on the same cohort of cell lines used for gene expression analysis (six 15q13.3 deletion clonal lines and six control clonal lines at the iPSC and iN stages). One iN control line was excluded from final analysis due to clustering with iPSCs rather than iNs. Within the 15q13.3 microdeletion, no differentially methylated regions (DMRs) were identified in iPSCs or iNs with the exception of one DMR located in the gene body of non-coding RNA LINC02352. The absence of significant DNA methylation changes in the 15q13.3 genes was consistent with the lack of dosage compensation seen in the gene expression data. In addition, we did not observe an enrichment in DMRs within 5 Mb of the 15q13.3 microdeletion.
Genome-wide, 416 DMRs were identified in iPSCs and were annotated to 147 promoter regions, 404 gene bodies, and 77 intergenic regions (Figs. 3a, c and Supplementary Table S3 ). At the iN level, 408 DMRs were identified and annotated to 160 promoter regions, 277 gene bodies, and 80 intergenic regions (Figs. 3b, d and Supplementary Table S4 ). After assigning each gene to a unique DMR, we obtained a list of 355 differentially methylated genes in iPSCs and 365 differentially methylated genes in iNs. The effect direction for the mean methylation difference between cases and controls was concordant for 215 out of 216 genes differentially methylated in both iPSCs and iNs, suggesting a high degree of similarity in DNA methylation patterns between the two tissues. The one exception that was non-concordant was a gene associated with two different DMRs in the two tissue types.
We performed gene set enrichment analysis using the lists of DMR-associated genes. In both iPSCs and iNs, we observed an enrichment in the gene ontology biological process (GOBP) category of cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742). Under the category of PANTHER pathways, both the cadherin signaling pathway (P00012) and the Wnt signaling pathway (P00057) were enriched in iPSCs and iNs (Figs. 3e, f). The enriched PANTHER and GOBP terms were mainly driven by a large number of DMRs located near protocadherins (PCDHs) (Figs. 3g, h, i), which are cell-adhesion proteins primarily expressed in the developing nervous system [43] . PCDHs have been directly implicated in several neuronal disorders, including epilepsy, autism, and schizophrenia [44] . Specifically, differential methylation of PCDHs has been observed in a number of neurodevelopmental disorders, including Down syndrome, Williams-Beuren syndrome, 7q11.23 duplication syndrome, and depression [45] . Besides the protocadherin-related pathways, we also observed an enrichment in two other neuronally related categories within iNs: the KEGG category of nicotine addition (hsa05033) and the gene ontology molecular function category of GABA receptor activity (GO:0016917) ( Fig. 3f ). 
Chromatin accessibility analysis
We examined chromatin accessibility in three 15q13. 3 intergenic regions in iNs (Figs. 4c, d) . After assigning each gene to a unique peak, we identified 45 differentially accessible genes in iPSCs and 68 differentially accessible genes in iNs. Five genes were differentially accessible in both tissues, all with a concordant direction of effect for the chromatin accessibility change between cases and controls.
We next examined transcription factor binding sites (TFBSs) enriched in a list of differentially open promoters, generated as previously described [30] . In iPSCs, three enriched motifs (pval<=10-12)
were associated with transcription factors that were expressed in the same tissue: ZNF711, MZF1, and MED1 (Fig. 4e ). In iNs, five expressed transcription factors associated with enriched motifs (pval<=10-12) were similarly identified: MAX, ETV6, GRHL2, TWIST1, and SOX5 (Fig. 4f ). Out of the eight transcription factors associated with enriched motifs across iPSCs and iNs, four (ZNF711, MZF1, MAX, SOX5) have been previously implicated in neuropsychiatric disorders. Variants in ZNF711 and MZF1 have been associated with non-syndromic intellectual disability and Alzheimer's disease, respectively [46, 47] . Genetic variants in SOX5 have been associated with a range of neuropsychiatric disorders, including major depressive disorder [48] , amyotrophic lateral sclerosis [49] , Alzheimer's disease [50] and intellectual disability [51] . Lastly, the transcription factor MAX has been linked to depression-like behaviors in mouse models [52] and has been shown to be down-regulated in the dorsolateral prefrontal cortex of schizophrenia patients [53] . (e, f). Enriched motifs in iPSCs and iNs from de novo Homer analysis with p-value <= 10 -12 , best match transcription factor expressed in the same tissue, and best match score >= 0.6.
Correlation and overlap analysis
To determine if the RNA-Seq, Methyl-Seq and ATAC-Seq omics data sets exhibited a linear relationship, we calculated pairwise Pearson correlations between transcription, promoter-associated DNA methylation and promoter-associated chromatin accessibility. A weak positive correlation was seen between transcription and chromatin accessibility in both iPSCs (R=0.21, p=0.019) and iNs (R=0.27, p=2.5x10 -6 ) (Figs. 5a, d) . A weak negative correlation was seen between transcription and methylation in iNs (R=− 0.22, p =1.4x10 -5 ) (Fig. 5e ). The correlation between transcription and methylation in iPSCs was also negative but was nonsignificant (R=-0.14, p=0.053) ( Fig. 5b) . A strong negative correlation was observed between methylation and chromatin accessibility in iPSCs (R=-0.67, p<2.2x10 -16 ) and iNs (R=−0.64, p<2.2x10 -16 ) (Figs. 5c, f) . These trends were consistent with the expected positive correlation between chromatin accessibility and transcription, the expected negative correlation between DNA methylation and transcription, and the expected negative correlation between DNA methylation and chromatin accessibility.
We also calculated pairwise correlations between transcription, DNA methylation and chromatin accessibility, between the two tissue types. Between transcription and chromatin accessibility, no significant correlation was observed ( Supplementary Figs. S1d, h) . Between transcription and DNA methylation, a very weak negative correlation was observed ( Supplementary   Figs. S1e, i) . A moderate to strong negative correlation was seen between methylation and chromatin accessibility between different tissue types ( Supplementary Figs. S1f, g) . Finally, we examined the correlation between tissue types within each omics analysis, e.g. between iPSC transcription and iN transcription. We observed a moderate positive correlation for transcription (R=0.56, p<2.6x10 -16 ), a very strong positive correlation for DNA methylation (R=0.92, p< 2.2x10 -16 ), and a very strong positive correlation for chromatin accessibility (R=0.84, p< 2.6x10 -5 ) ( Supplementary Figs. S1a, b, c) . Despite the significant linear correlation between the three omics data sets within each tissue type, the overlap in significant genes was very limited. Only 15 genes were significant across at least two omics data sets in iPSCs and 13 genes were significant across at least two data sets in iNs. A single gene, KCNH8, was significant in all three omics analyses for iNs. KCNH8 encodes a voltage gated potassium channel that is primarily expressed in the nervous system [54] . We also identified four genes that were significant in multiple omics data sets in both iPSCs and iNs. Interestingly, all four have been implicated in studies of neuropsychiatric disorders. These genes were CNTN4, a cell adhesion molecule associated with autism [55] and schizophrenia [56] ; PCDHGA10, a member of the protocadherin family of cell adhesion proteins which has been implicated in schizophrenia and autism [44] ; SLC39A4, a zinc transport protein known to be regulated by SHANK3, a highly penetrant risk factor for autism [57] ; and SORCS1, which alters amyloid precursor protein processing and is associated with Alzheimer's disease [58] .
Discussion
Our multi-omics analysis of iPSCs and iPSC-derived iNs carrying the 15q13.3 microdeletion allowed us to interrogate the global molecular impact of a large CNV that is strongly associated with a range of neuropsychiatric disorders. Within the 15q13.3 microdeletion, the genes CHRNA7, KLF13, MTMR10, OTUD7A, FAN1, and ARHGAP11B were expressed in both iPSCs and iNs. The remaining protein-coding gene in the region, TRPM1, was not expressed above threshold levels in iPSCs or iNs, which is in agreement with previous expression data suggesting it is primarily expressed in the retina [59] . In both iPSCs and iNs, all expressed genes had decreased expression in deletion samples, suggesting simple dosage sensitivity as a mechanism of action. We did not see significant changes in DNA methylation or chromatin accessibility within the deletion after accounting for the change in copy number, which was consistent with the lack of dosage compensation observed in the gene expression data. We also did not observe a position effect, in which genes near (within 5 Mb) but outside the CNV are affected.
We saw genome-wide changes in the expression, DNA methylation and chromatin accessibility patterns of iPSCs and iPSC-derived neurons as a result of the 15q13.3 microdeletion. In the pairwise correlation analyses of the omics data sets, DNA methylation had a negative correlation with both transcription and chromatin accessibility, whereas transcription and chromatin accessibility were positively correlated. The Pearson correlation between DNA methylation and chromatin accessibility was much stronger than their respective correlations with transcription. This trend held true even when comparing DNA methylation and chromatin accessibility across different tissues, and was likely due to the greater stability of the epigenome compared with gene expression. Both the direction and relative strength of correlation between these three omics layers were consistent with a recent study that profiled transcription, methylation and accessibility in mouse embryonic stem cells. In the promoter-associated pseudo-bulk data from that study, DNA methylation-accessibility had the highest correlation coefficient, followed by DNA methylation-transcription and accessibility-transcription [60] .
At the gene expression level, our analysis in iNs compared with the analysis in iPSCs revealed a greater number of changes in neuropsychiatric-related genes and pathways. Among the list of differentially expressed iN genes, two of particular interest were PRODH and DGCR6, which are major candidate genes in the 22q11.2 microdeletion, another large CNV like the 15q13.3 microdeletion that is strongly associated with increased risk of neuropsychiatric disorders [61] . From the gene set enrichment analysis, the gene ontology molecular function categories enriched in iNs included a number of processes tied to abnormal neurodevelopment, such as Wnt binding, ribosome biogenesis, and DNA binding. Wnt signaling plays an important role in a number of neurodevelopmental and neurophysiological processes, such as synapse assembly, neuronal generation and differentiation, and glutamatergic and GABAergic neurotransmission [62] . Changes in the expression of Wnt pathway components are associated with several neuronal disorders including schizophrenia, bipolar disorder, Alzheimer's disease, and autism [63] . Similarly, the dysregulation of ribosome biogenesis has been implicated in neuropsychiatric disorders in previous studies of postmortem brains [64, 65] , olfactory neurosphere derived cells [66] , and neural progenitor cells [67] . Another enriched gene ontology category, damaged DNA binding, is also known to play a key role in neuropsychiatric disorders.
Mutations in DNA repair genes have been linked to schizophrenia and autism [68] , and oxidative stress, a major trigger of DNA damage, has been associated with a number of neuropsychiatric disorders including major depressive disorder, bipolar disorder, and schizophrenia [69] .
In our analysis of the epigenome, we also identified an enrichment in genes connected to Wnt signaling, although the specific genes involved did not significantly overlap with those affected at the gene expression level. In the DNA methylation analysis, the top PANTHER pathways enriched in both iPSCs and iNs were cadherin signaling and Wnt signaling. The genes differentially methylated in these pathways were primarily composed of protocadherins, a group of cell adhesion genes known to modulate the Wnt signaling pathway [70, 71] . From the chromatin accessibility analysis, we also identified several transcription factors with known connections to Wnt signaling, including MZF1, whose transcription factor binding sites are enriched in promoters of Wnt pathway genes [72] ; TWIST1, which is activated by canonical Wnt signaling [73] ; and SOX5, which is associated with WNT signaling activity in human SH-SY5Y neuroblastoma cells [50] .
In addition to the convergence on the Wnt signaling pathway, our multi-omics analysis identified four genes (CNTN4, PCDHGA10, SLC39A4, SORCS1) enriched in multiple omics data sets in both iPSCs and iNs. All four genes have been previously associated with schizophrenia, autism, or Alzheimer's disease. This enrichment of previously reported neuropsychiatric associated genes and pathways in the omics overlap analysis suggests that integrating multiple omics layers could help us narrow down on candidate genes and molecular networks for CNV-associated psychiatric disorders like the 15q13.3 microdeletion syndrome, which often have a high degree of variability at the phenotypic and likely molecular level.
Follow-up studies can now be conducted that will use more than the single neuronal cell type used here, which were early-stage induced neurons that can mature to resemble excitatory projection neurons. Given the diverse range of phenotypes associated with the 15q13.3 microdeletion, it would be beneficial in future studies to look at other neuronal cell types, which may be affected differently by the CNV, as well as their interactions with glial cells also carrying the microdeletion.
In conclusion, we generated iPSCs and iNs with the most common variant of the 15q13.3 microdeletion, which provide a useful tool to study this large CNV as well as acting as an entry point for understanding the molecular etiology of major neuropsychiatric disorders in general. Our analysis of these cell lines showed that all expressed genes within the CNV region are down-regulated following the change in DNA copy number, supporting the model that haploinsufficiency of genes within the deleted regions forms the molecular basis of the observed phenotypes. Our analyses of gene expression, DNA methylation and chromatin accessibility revealed downstream changes that were both global in nature and affecting discrete loci, genes, gene families and pathways, such as Wnt signaling, ribosome function, DNA binding, and cell adhesion, suggesting these molecular pathways may be disrupted in 15q13.3 microdeletion patients during brain development and brain function. Beyond the analysis of the 15q13.3 microdeletion, our study provides a blueprint for assaying the molecular consequences of large neuropsychiatric chromosomal aberrations in general. The many points of convergence with loci already associated with normal and abnormal brain function underline how the study of variants such as those on chromosome 15q13.3 can inform our general understanding of the molecular basis of neuropsychiatric disorders.
